The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy
Open Access
- 7 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
Abstract
Background: Xerostomia is one of the most common adverse events of radiotherapy in head and neck cancer patients. There have been many reports on functional changes of the parotid gland after radiation therapy, but there have been few reports on the volume of the parotid gland and its relationship with oral quality of life (QOL) and even fewer reports on longitudinal change of the parotid gland volume. The purpose of this study was to evaluate the long-term change of the parotid gland volume after intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma and the relationship between parotid irradiation dose and xerostomia symptoms. Methods: We retrospectively analyzed 26 patients with nasopharyngeal cancer treated by IMRT. Longitudinal changes of parotid gland volumes after IMRT were evaluated on CT images. The parotid gland volumes in each period were converted to the ratio to parotid gland volumes before radiotherapy (relative parotid volume). Dunnett’s test was used to evaluate the longitudinal changes in relative parotid volumes at 0-6, 7-18, 19-30, 31-42, 43-54 and 55-66 months after IMRT. We assessed xerostomia 3 years or more after IMRT by measuring the degree of oral moisture using a moisture-checking device (Mucus, Life Co., Ltd.) and oral QOL evaluation by GOHAI (General Oral Health Assessment Index). Results: The relative parotid volumes during radiotherapy and at 0-6, 7-18, 19-30, 31-42, 43-54 and 55-66 months after IMRT were 75.2 ± 14.3%, 67.2 ± 11.4%, 68.5 ± 15.9%, 72.4 ± 14.8%, 73.0 ± 13.8%, 76.2 ± 17.5%, and 77.1% ± 17.3%, respectively. The parotid volume had recovered significantly at 43-54 and 55-66 months after IMRT, especially in parotids receiving less than 40 Gy as the mean dose. The mean irradiated dose for bilateral parotids showed negative correlations with oral QOL score and oral moisture after a long period. Conclusions: The parotid volume recovered gradually but had not reached a plateau even 3 years after radiotherapy, especially in parotids receiving less than 40 Gy as the mean dose.This publication has 21 references indexed in Scilit:
- Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical studyRadiation Oncology, 2011
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Longitudinal Changes over 2 Years in Parotid Glands of Patients Treated with Preoperative 30-Gy Irradiation for Oral CancerJapanese Journal of Clinical Oncology, 2011
- Xerostomia in head and neck malignancyOral Oncology, 2010
- The influence of different irradiation doses and desensitizer application on demineralization of human dentinOral Oncology, 2009
- Radiation‐induced xerostomia in patients with head and neck cancerCancer, 2006
- Dose–volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapyEndocrine, 2005
- Importance of the Initial Volume of Parotid Glands in Xerostomia for Patients with Head and Neck Cancers Treated with IMRTJapanese Journal of Clinical Oncology, 2005
- Structural and functional injury in minipig salivary glands following fractionated exposure to 70 Gy of ionizing radiation: an animal model for human radiation-induced salivary gland injuryOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2003
- Late effects of radiation therapy in the head and neck regionEndocrine, 1995